Structure

Physi-Chem Properties

Molecular Weight:  225.1
Volume:  219.948
LogP:  -1.27
LogD:  -0.204
LogS:  -0.322
# Rotatable Bonds:  2
TPSA:  92.95
# H-Bond Aceptor:  5
# H-Bond Donor:  5
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.451
Synthetic Accessibility Score:  3.596
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.412
MDCK Permeability:  7.97919256001478e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.275
Human Intestinal Absorption (HIA):  0.831
20% Bioavailability (F20%):  0.996
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.133
Plasma Protein Binding (PPB):  28.129600524902344%
Volume Distribution (VD):  1.192
Pgp-substrate:  75.57917022705078%

ADMET: Metabolism

CYP1A2-inhibitor:  0.041
CYP1A2-substrate:  0.051
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.52
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.652
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.269
CYP3A4-inhibitor:  0.018
CYP3A4-substrate:  0.068

ADMET: Excretion

Clearance (CL):  6.143
Half-life (T1/2):  0.752

ADMET: Toxicity

hERG Blockers:  0.059
Human Hepatotoxicity (H-HT):  0.9
Drug-inuced Liver Injury (DILI):  0.26
AMES Toxicity:  0.067
Rat Oral Acute Toxicity:  0.011
Maximum Recommended Daily Dose:  0.035
Skin Sensitization:  0.208
Carcinogencity:  0.02
Eye Corrosion:  0.005
Eye Irritation:  0.033
Respiratory Toxicity:  0.415

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC208757

Natural Product ID:  NPC208757
Common Name*:   Radicamine B
IUPAC Name:   (2R,3R,4R,5R)-2-(hydroxymethyl)-5-(4-hydroxyphenyl)pyrrolidine-3,4-diol
Synonyms:  
Standard InCHIKey:  BRPXIQPSCKPBLH-GWOFURMSSA-N
Standard InCHI:  InChI=1S/C11H15NO4/c13-5-8-10(15)11(16)9(12-8)6-1-3-7(14)4-2-6/h1-4,8-16H,5H2/t8-,9-,10-,11-/m1/s1
SMILES:  OC[C@H]1N[C@@H]([C@H]([C@@H]1O)O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL466791
PubChem CID:   15953621
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000218] Pyrrolidines
        • [CHEMONTID:0002336] Phenylpyrrolidines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 200000.0 nM PMID[464309]
NPT2 Others Unspecified IC50 = 24000.0 nM PMID[464309]
NPT2 Others Unspecified IC50 = 10000.0 nM PMID[464309]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC208757 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8493 Intermediate Similarity NPC160931
0.8493 Intermediate Similarity NPC37205
0.8203 Intermediate Similarity NPC137096
0.8189 Intermediate Similarity NPC213
0.8189 Intermediate Similarity NPC10286
0.8134 Intermediate Similarity NPC323775
0.8134 Intermediate Similarity NPC236347
0.7907 Intermediate Similarity NPC101139
0.7902 Intermediate Similarity NPC204546
0.7868 Intermediate Similarity NPC322366
0.7857 Intermediate Similarity NPC290566
0.7857 Intermediate Similarity NPC145638
0.7842 Intermediate Similarity NPC302171
0.7842 Intermediate Similarity NPC33338
0.7842 Intermediate Similarity NPC300020
0.7832 Intermediate Similarity NPC323123
0.7794 Intermediate Similarity NPC318965
0.7762 Intermediate Similarity NPC211468
0.7762 Intermediate Similarity NPC170170
0.7762 Intermediate Similarity NPC219233
0.7744 Intermediate Similarity NPC118522
0.7744 Intermediate Similarity NPC169207
0.7744 Intermediate Similarity NPC115627
0.7727 Intermediate Similarity NPC85276
0.76 Intermediate Similarity NPC147000
0.76 Intermediate Similarity NPC226778
0.76 Intermediate Similarity NPC304761
0.76 Intermediate Similarity NPC150254
0.7586 Intermediate Similarity NPC251439
0.7552 Intermediate Similarity NPC64205
0.7536 Intermediate Similarity NPC320242
0.7518 Intermediate Similarity NPC307020
0.75 Intermediate Similarity NPC29601
0.7464 Intermediate Similarity NPC171372
0.7448 Intermediate Similarity NPC214988
0.744 Intermediate Similarity NPC327226
0.7419 Intermediate Similarity NPC125732
0.7405 Intermediate Similarity NPC146422
0.7386 Intermediate Similarity NPC476268
0.7383 Intermediate Similarity NPC294249
0.7347 Intermediate Similarity NPC168861
0.7343 Intermediate Similarity NPC247018
0.7343 Intermediate Similarity NPC307123
0.7343 Intermediate Similarity NPC97870
0.7308 Intermediate Similarity NPC147091
0.7286 Intermediate Similarity NPC136112
0.7286 Intermediate Similarity NPC141739
0.7279 Intermediate Similarity NPC283760
0.7273 Intermediate Similarity NPC277669
0.7273 Intermediate Similarity NPC76213
0.7255 Intermediate Similarity NPC207824
0.7255 Intermediate Similarity NPC60538
0.7244 Intermediate Similarity NPC68055
0.7222 Intermediate Similarity NPC289381
0.7222 Intermediate Similarity NPC155847
0.7205 Intermediate Similarity NPC195392
0.72 Intermediate Similarity NPC303611
0.72 Intermediate Similarity NPC226096
0.72 Intermediate Similarity NPC290515
0.72 Intermediate Similarity NPC164514
0.72 Intermediate Similarity NPC108606
0.7185 Intermediate Similarity NPC188867
0.7185 Intermediate Similarity NPC281686
0.7185 Intermediate Similarity NPC106551
0.7183 Intermediate Similarity NPC145888
0.7183 Intermediate Similarity NPC16031
0.7183 Intermediate Similarity NPC161593
0.7179 Intermediate Similarity NPC477564
0.7179 Intermediate Similarity NPC2295
0.7172 Intermediate Similarity NPC267237
0.717 Intermediate Similarity NPC205167
0.7153 Intermediate Similarity NPC329595
0.7153 Intermediate Similarity NPC326599
0.7152 Intermediate Similarity NPC125852
0.7107 Intermediate Similarity NPC92191
0.7107 Intermediate Similarity NPC59028
0.7103 Intermediate Similarity NPC88667
0.7097 Intermediate Similarity NPC20142
0.7097 Intermediate Similarity NPC476742
0.7097 Intermediate Similarity NPC215351
0.7095 Intermediate Similarity NPC238412
0.7087 Intermediate Similarity NPC214200
0.7087 Intermediate Similarity NPC228400
0.7075 Intermediate Similarity NPC109580
0.7073 Intermediate Similarity NPC474475
0.7067 Intermediate Similarity NPC326241
0.7063 Intermediate Similarity NPC249274
0.7055 Intermediate Similarity NPC210140
0.7055 Intermediate Similarity NPC328494
0.7051 Intermediate Similarity NPC476741
0.7051 Intermediate Similarity NPC244509
0.7048 Intermediate Similarity NPC119652
0.7048 Intermediate Similarity NPC97526
0.7044 Intermediate Similarity NPC79328
0.7037 Intermediate Similarity NPC280022
0.7037 Intermediate Similarity NPC134858
0.703 Intermediate Similarity NPC470739
0.703 Intermediate Similarity NPC225597
0.703 Intermediate Similarity NPC477640
0.7029 Intermediate Similarity NPC239697
0.7013 Intermediate Similarity NPC473491
0.7013 Intermediate Similarity NPC476743
0.7012 Intermediate Similarity NPC475686
0.7012 Intermediate Similarity NPC58766
0.7006 Intermediate Similarity NPC133011
0.7006 Intermediate Similarity NPC82285
0.7 Intermediate Similarity NPC474862
0.7 Intermediate Similarity NPC27581
0.6987 Remote Similarity NPC274026
0.6985 Remote Similarity NPC317254
0.6981 Remote Similarity NPC29647
0.698 Remote Similarity NPC253429
0.698 Remote Similarity NPC48202
0.698 Remote Similarity NPC471201
0.6977 Remote Similarity NPC178902
0.6975 Remote Similarity NPC233650
0.6975 Remote Similarity NPC293871
0.6975 Remote Similarity NPC124433
0.697 Remote Similarity NPC471165
0.6968 Remote Similarity NPC147390
0.6968 Remote Similarity NPC428
0.6968 Remote Similarity NPC135538
0.6968 Remote Similarity NPC24233
0.6968 Remote Similarity NPC246587
0.6968 Remote Similarity NPC476744
0.6968 Remote Similarity NPC476571
0.6962 Remote Similarity NPC323336
0.6962 Remote Similarity NPC326349
0.6957 Remote Similarity NPC97072
0.6957 Remote Similarity NPC215829
0.6951 Remote Similarity NPC89831
0.6933 Remote Similarity NPC209377
0.6933 Remote Similarity NPC476989
0.6923 Remote Similarity NPC262166
0.6918 Remote Similarity NPC244336
0.6913 Remote Similarity NPC313694
0.6913 Remote Similarity NPC242159
0.6912 Remote Similarity NPC142599
0.6912 Remote Similarity NPC118202
0.6909 Remote Similarity NPC266176
0.6909 Remote Similarity NPC158148
0.6909 Remote Similarity NPC290759
0.6909 Remote Similarity NPC82533
0.6903 Remote Similarity NPC191376
0.6903 Remote Similarity NPC179825
0.6903 Remote Similarity NPC321505
0.6901 Remote Similarity NPC140359
0.6901 Remote Similarity NPC318777
0.6901 Remote Similarity NPC13020
0.6899 Remote Similarity NPC91461
0.6899 Remote Similarity NPC7686
0.6899 Remote Similarity NPC40258
0.6897 Remote Similarity NPC271808
0.689 Remote Similarity NPC193853
0.689 Remote Similarity NPC223077
0.689 Remote Similarity NPC56887
0.6886 Remote Similarity NPC2314
0.6884 Remote Similarity NPC311737
0.6884 Remote Similarity NPC38458
0.6883 Remote Similarity NPC185838
0.688 Remote Similarity NPC138117
0.688 Remote Similarity NPC325292
0.6875 Remote Similarity NPC321561
0.6871 Remote Similarity NPC149379
0.6867 Remote Similarity NPC193528
0.6866 Remote Similarity NPC474149
0.6855 Remote Similarity NPC300017
0.6852 Remote Similarity NPC63931
0.6848 Remote Similarity NPC100566
0.6848 Remote Similarity NPC150879
0.6848 Remote Similarity NPC181653
0.6848 Remote Similarity NPC190332
0.6842 Remote Similarity NPC13696
0.6842 Remote Similarity NPC476575
0.6842 Remote Similarity NPC97811
0.6842 Remote Similarity NPC153690
0.6835 Remote Similarity NPC317784
0.6835 Remote Similarity NPC142638
0.6831 Remote Similarity NPC298486
0.6829 Remote Similarity NPC121275
0.6829 Remote Similarity NPC4138
0.6829 Remote Similarity NPC284183
0.6824 Remote Similarity NPC160692
0.6822 Remote Similarity NPC213730
0.6821 Remote Similarity NPC197921
0.6818 Remote Similarity NPC231705
0.6815 Remote Similarity NPC103379
0.6815 Remote Similarity NPC56685
0.6815 Remote Similarity NPC477565
0.6813 Remote Similarity NPC172765
0.6813 Remote Similarity NPC193949
0.6813 Remote Similarity NPC110416
0.6813 Remote Similarity NPC207757
0.6813 Remote Similarity NPC469428
0.6813 Remote Similarity NPC249797
0.6813 Remote Similarity NPC184026
0.6813 Remote Similarity NPC5238
0.6813 Remote Similarity NPC39701
0.6813 Remote Similarity NPC127674
0.6813 Remote Similarity NPC204828

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC208757 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.837 Intermediate Similarity NPD1132 Approved
0.837 Intermediate Similarity NPD1130 Approved
0.837 Intermediate Similarity NPD1136 Approved
0.8346 Intermediate Similarity NPD317 Approved
0.8346 Intermediate Similarity NPD318 Approved
0.8321 Intermediate Similarity NPD817 Approved
0.8321 Intermediate Similarity NPD823 Approved
0.8296 Intermediate Similarity NPD601 Approved
0.8296 Intermediate Similarity NPD598 Approved
0.8296 Intermediate Similarity NPD597 Approved
0.8281 Intermediate Similarity NPD316 Approved
0.8203 Intermediate Similarity NPD16 Approved
0.8203 Intermediate Similarity NPD856 Approved
0.8203 Intermediate Similarity NPD9613 Approved
0.8203 Intermediate Similarity NPD9615 Approved
0.8203 Intermediate Similarity NPD9616 Approved
0.8134 Intermediate Similarity NPD9619 Approved
0.8134 Intermediate Similarity NPD9621 Approved
0.8134 Intermediate Similarity NPD9620 Approved
0.8106 Intermediate Similarity NPD2561 Approved
0.8106 Intermediate Similarity NPD2562 Approved
0.806 Intermediate Similarity NPD1129 Approved
0.806 Intermediate Similarity NPD1133 Approved
0.806 Intermediate Similarity NPD1135 Approved
0.806 Intermediate Similarity NPD1134 Approved
0.806 Intermediate Similarity NPD1131 Approved
0.8058 Intermediate Similarity NPD2568 Approved
0.8043 Intermediate Similarity NPD3059 Approved
0.8043 Intermediate Similarity NPD3061 Approved
0.8043 Intermediate Similarity NPD3062 Approved
0.8 Intermediate Similarity NPD602 Approved
0.8 Intermediate Similarity NPD599 Approved
0.7969 Intermediate Similarity NPD9614 Approved
0.7969 Intermediate Similarity NPD9618 Approved
0.7929 Intermediate Similarity NPD5314 Approved
0.791 Intermediate Similarity NPD9622 Approved
0.7868 Intermediate Similarity NPD859 Approved
0.7868 Intermediate Similarity NPD858 Approved
0.7857 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD9381 Approved
0.7744 Intermediate Similarity NPD9384 Approved
0.7714 Intermediate Similarity NPD6407 Approved
0.7714 Intermediate Similarity NPD6405 Approved
0.7703 Intermediate Similarity NPD2874 Phase 2
0.7687 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD3055 Approved
0.7664 Intermediate Similarity NPD3053 Approved
0.7639 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD3555 Approved
0.7622 Intermediate Similarity NPD3552 Approved
0.7622 Intermediate Similarity NPD3553 Approved
0.7622 Intermediate Similarity NPD3554 Approved
0.76 Intermediate Similarity NPD9610 Approved
0.76 Intermediate Similarity NPD310 Approved
0.76 Intermediate Similarity NPD311 Approved
0.76 Intermediate Similarity NPD314 Approved
0.76 Intermediate Similarity NPD10 Approved
0.76 Intermediate Similarity NPD9608 Approved
0.76 Intermediate Similarity NPD309 Approved
0.76 Intermediate Similarity NPD315 Approved
0.7536 Intermediate Similarity NPD1820 Approved
0.7536 Intermediate Similarity NPD4103 Phase 2
0.7536 Intermediate Similarity NPD1817 Approved
0.7536 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.7536 Intermediate Similarity NPD1818 Approved
0.7536 Intermediate Similarity NPD1819 Approved
0.7532 Intermediate Similarity NPD2977 Approved
0.7532 Intermediate Similarity NPD2978 Approved
0.7518 Intermediate Similarity NPD4659 Approved
0.7465 Intermediate Similarity NPD829 Discontinued
0.7464 Intermediate Similarity NPD9634 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD5311 Approved
0.7464 Intermediate Similarity NPD5310 Approved
0.745 Intermediate Similarity NPD3845 Phase 1
0.745 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD3054 Approved
0.7431 Intermediate Similarity NPD3052 Approved
0.7405 Intermediate Similarity NPD9379 Approved
0.7405 Intermediate Similarity NPD9377 Approved
0.7397 Intermediate Similarity NPD9570 Approved
0.7394 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD5137 Approved
0.7365 Intermediate Similarity NPD3060 Approved
0.7365 Intermediate Similarity NPD3638 Discontinued
0.7343 Intermediate Similarity NPD1423 Approved
0.7324 Intermediate Similarity NPD3179 Approved
0.7324 Intermediate Similarity NPD3180 Approved
0.7324 Intermediate Similarity NPD3167 Approved
0.7324 Intermediate Similarity NPD3165 Approved
0.7324 Intermediate Similarity NPD3164 Approved
0.7324 Intermediate Similarity NPD3166 Approved
0.7286 Intermediate Similarity NPD1794 Approved
0.7273 Intermediate Similarity NPD2028 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5160 Discontinued
0.7248 Intermediate Similarity NPD2460 Phase 3
0.7248 Intermediate Similarity NPD2458 Approved
0.7248 Intermediate Similarity NPD4162 Approved
0.7248 Intermediate Similarity NPD2459 Approved
0.7237 Intermediate Similarity NPD3536 Discontinued
0.7237 Intermediate Similarity NPD3645 Discontinued
0.723 Intermediate Similarity NPD6809 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD3136 Phase 2
0.72 Intermediate Similarity NPD9611 Approved
0.72 Intermediate Similarity NPD9609 Approved
0.72 Intermediate Similarity NPD9612 Approved
0.72 Intermediate Similarity NPD7066 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD9568 Approved
0.7183 Intermediate Similarity NPD9569 Approved
0.7179 Intermediate Similarity NPD7118 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD854 Approved
0.7165 Intermediate Similarity NPD855 Approved
0.7162 Intermediate Similarity NPD3175 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD302 Approved
0.7133 Intermediate Similarity NPD596 Approved
0.7133 Intermediate Similarity NPD600 Approved
0.7123 Intermediate Similarity NPD555 Phase 2
0.7114 Intermediate Similarity NPD7978 Discontinued
0.7113 Intermediate Similarity NPD558 Phase 2
0.7107 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD3162 Approved
0.7103 Intermediate Similarity NPD3163 Approved
0.7103 Intermediate Similarity NPD259 Phase 1
0.7095 Intermediate Similarity NPD1753 Discontinued
0.709 Intermediate Similarity NPD2234 Approved
0.709 Intermediate Similarity NPD2228 Approved
0.709 Intermediate Similarity NPD2229 Approved
0.708 Intermediate Similarity NPD5303 Approved
0.708 Intermediate Similarity NPD5304 Approved
0.708 Intermediate Similarity NPD2227 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD2239 Approved
0.7047 Intermediate Similarity NPD2240 Approved
0.7039 Intermediate Similarity NPD8131 Suspended
0.7034 Intermediate Similarity NPD864 Approved
0.7034 Intermediate Similarity NPD865 Approved
0.7029 Intermediate Similarity NPD1710 Approved
0.7025 Intermediate Similarity NPD4227 Discontinued
0.6986 Remote Similarity NPD554 Clinical (unspecified phase)
0.6981 Remote Similarity NPD6283 Phase 2
0.6966 Remote Similarity NPD9537 Phase 1
0.6966 Remote Similarity NPD9536 Phase 1
0.6943 Remote Similarity NPD6056 Approved
0.6943 Remote Similarity NPD6057 Approved
0.6939 Remote Similarity NPD3597 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3557 Approved
0.6937 Remote Similarity NPD3559 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3556 Approved
0.6937 Remote Similarity NPD3560 Approved
0.6937 Remote Similarity NPD3558 Approved
0.6912 Remote Similarity NPD1791 Approved
0.6912 Remote Similarity NPD1793 Approved
0.6908 Remote Similarity NPD5062 Approved
0.6908 Remote Similarity NPD4236 Phase 3
0.6908 Remote Similarity NPD4237 Approved
0.6908 Remote Similarity NPD5061 Approved
0.6908 Remote Similarity NPD2976 Clinical (unspecified phase)
0.6906 Remote Similarity NPD1922 Discontinued
0.6903 Remote Similarity NPD3158 Phase 1
0.6903 Remote Similarity NPD3157 Approved
0.689 Remote Similarity NPD4652 Approved
0.6884 Remote Similarity NPD828 Approved
0.6879 Remote Similarity NPD3687 Approved
0.6879 Remote Similarity NPD5351 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5350 Clinical (unspecified phase)
0.6879 Remote Similarity NPD3686 Approved
0.6875 Remote Similarity NPD257 Approved
0.6875 Remote Similarity NPD258 Approved
0.6875 Remote Similarity NPD6818 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7451 Discontinued
0.6871 Remote Similarity NPD2041 Clinical (unspecified phase)
0.6871 Remote Similarity NPD2042 Clinical (unspecified phase)
0.6861 Remote Similarity NPD255 Approved
0.6861 Remote Similarity NPD256 Approved
0.6859 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6859 Remote Similarity NPD52 Approved
0.6859 Remote Similarity NPD7526 Approved
0.6839 Remote Similarity NPD2421 Approved
0.6839 Remote Similarity NPD2420 Approved
0.6824 Remote Similarity NPD825 Approved
0.6824 Remote Similarity NPD826 Approved
0.6818 Remote Similarity NPD1444 Approved
0.6818 Remote Similarity NPD2677 Approved
0.6818 Remote Similarity NPD1445 Approved
0.6818 Remote Similarity NPD5241 Discontinued
0.6795 Remote Similarity NPD3985 Discontinued
0.6795 Remote Similarity NPD6419 Discontinued
0.6791 Remote Similarity NPD550 Approved
0.6791 Remote Similarity NPD551 Approved
0.6788 Remote Similarity NPD595 Approved
0.6788 Remote Similarity NPD593 Approved
0.6784 Remote Similarity NPD5895 Clinical (unspecified phase)
0.6776 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6774 Remote Similarity NPD3122 Phase 3
0.6772 Remote Similarity NPD814 Clinical (unspecified phase)
0.677 Remote Similarity NPD5772 Approved
0.677 Remote Similarity NPD3465 Clinical (unspecified phase)
0.677 Remote Similarity NPD5773 Approved
0.6768 Remote Similarity NPD4666 Phase 3
0.6759 Remote Similarity NPD2195 Approved
0.6759 Remote Similarity NPD2194 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data